Previous Page  7 / 28 Next Page
Information
Show Menu
Previous Page 7 / 28 Next Page
Page Background

Pathology 2018

Research & Reviews: Journal of Medical and Health Sciences

ISSN: 2319-9865

Page 62

October 08-09, 2018

Edinburgh, Scotland

17

th

International Conference on

Pathology & Cancer

Epidemiology

C

ancer is the second important morbidity and mortality factor

among women and the most incident type is breast cancer.

The diagnosis of biopsy tissue with hematoxylin and eosin (H&E)

stained images is non-trivial and specialists often disagree on

the final diagnosis. Actually, computer-aided diagnosis systems

contribute to reduce the cost and increase the efficiency of this

process. Therefore, we have established a diagnostic tool based

on a deep-learning framework for the screening of patients with

invasive ductal carcinoma. The dataset of tissue slides used in

this project consists of 30,000 samples from eligible patients

in our hospital. Available tissue samples above were split into a

training set, for learning the CNN parameters, and test set, for

evaluating its performance. An accuracy of 94% was obtained

for non-cancer (i.e. normal or benign) vs. malignant (i.e. invasive

carcinoma). This will be helping specialists identify cancerization

which is not visible under a single microscope, and this is just the

start of what we have planned.

Biography

Weidong Xie is a inventor, founder and CEO of DM Intelligence. Following

graduation from Imperial College London with honor in Biological Medicine

he took office as Associate Professor in Sun Yat-sen University and Direc-

tor/PI in St. Jude Children‘s Research Hospital, USA. His research results in

regards to T-cell viral immunity which is listed as the remarkable scientific

breakthroughs by famous journals. After a decade of experience in small

molecule drug discovery, he leads technology startups successfully and AI

in medical imaging & pathology diagnosis is the key point he focuses on.

wdxie@rukingbiotech.com

Weidong Xie

1

, Anjia Han

2

, Xunzhang Wang

3

, Tiantian Zhen

2

, Yan Yang

1

, Huijuan

Shi

2

, Elyas Mamatkadir

1

and

Jinwen Wang

3

1

The First Affiliated Hospital, Sun Yat-sen University, China

2

Sun Yat-sen University, China

3

DM Intelligence Ltd., China

Weidong Xie et al., RRJMHS 2018

Volume: 7

Classification of breast cancer histology images using deep

learning

Figure:

The prediction results of 2 samples in the validation

set AI(the black box)vs. pathologists (the yellow box).